Everest Kanto Cylinder Ltd

- There is no specific mention of any current or planned fundraising through debt or equity in the transcript. - Puneet Khurana stated they have adequate working capital limits and do not expect any pressure on margins due to interest costs, implying no immediate requirement for additional fundraising. - No discussion on new equity issuance or debt raising was brought up during the Q&A. - The company appears focused on executing existing capex plans (Mundra and Egypt plants) using current financial resources. In summary, based on the transcript from the Q2 FY26 earnings call, Everest Kanto Cylinder Limited has not indicated any new fundraising plans via debt or equity in the near future.

- Ongoing capex in two major plants: Mundra (₹130 crore spent, ₹30 crore balance) and Egypt (₹86 crore spent, ₹40 crore balance). - Egypt plant expected to start commercialization by January 2026; Mundra plant by March 2026. - Total capex expected to enhance manufacturing capabilities significantly, supporting wider domestic and international opportunities. - Expansion expected to support growth in CNG, industrial, and hydrogen markets. - No specific mention of any new strategic investments beyond these plants; focus remains on these expansions and capability building. - Company is also investing in strengthening teams and capabilities, especially for US market scale-up.

- Revenue guidance for standalone business is targeted between ₹900 crore to ₹1,000 crore in the current year. - Utilization currently at 70%, with potential to increase up to 80%, indicating room for volume growth. - Growth drivers include continued expansion in the CNG segment and industrial gases sectors. - New product lines and defense sector projects add to growth prospects. - Expansion through new plants in Mundra and Egypt, expected to begin commercial production by Q1 and Q2 FY27, enhancing manufacturing capabilities. - Order book visibility especially strong in the U.S. with an $80 million order book providing support for the next 12-18 months. - Positive outlook for 2-year growth trajectory supported by clean energy trends, semiconductor demand, and increasing hydrogen-related opportunities in mobility and industrial applications.

- The company expects steady revenue growth, targeting ₹900 to ₹1,000 crores in standalone revenue for the year. - EBITDA margin guidance is in the range of 12% to 14%, indicating stable operating profitability. - New plants in Mundra and Egypt are expected to enhance manufacturing capabilities and contribute to revenue growth in the near future (Egypt by January 2026, Mundra by March 2026). - Growth drivers include the expanding CNG segment, industrial gases (including new sectors like semiconductors and solar), and defense projects. - Hydrogen is seen as a complementary future growth area, with positive long-term prospects as the ecosystem develops. - International markets, particularly the U.S. with an $80 million order book and the Middle East, show promising order visibility supporting future earnings. - Overall, the company remains confident about its future growth, focusing on operational excellence and capacity expansion to drive earnings.

- The U.S. order book stands at approximately $80 million with an execution timeline of 12-18 months. - The Egypt plant is expected to contribute around ₹100 crores in revenue, and the Mundra plant approximately ₹200 crores; these are expected to be clearer in coming quarters. - The UAE order book is improving gradually with positive outlook; margins expected to improve as order book strengthens. - Overall combined order book across all locations is approximately ₹1,000 crores, executable over the next year. - The company is continuously adding new clients, especially in the industrial segment, though specific numbers for the quarter are not provided. - Defence sector orders exist but detailed information remains confidential.